Combotox, a 1:1 combination of anti-CD19 and anti-CD22 immunotoxins, was conjugated to deglycosylated RTA, which showed higher efficacy than either IT in pediatric precursor B-lineage acute lymphoblastic leukemia (pre-B ALL) [94]. Here, CD19 is linked to acute lymphoblastic leukemia.